In the present study, we described the frequency and spectrum of BRAF alterations in non-CRC GI malignancies by using a large database of patients who underwent tumor somatic profiling and compared it to the frequency of BRAF alteration in CRC. This evidence concerns the gene BRAF and neoplasm.